Chapter 11: HPV vaccines: commercial research & development.

@article{Inglis2006Chapter1H,
  title={Chapter 11: HPV vaccines: commercial research & development.},
  author={Stephen C Inglis and Alan Shaw and Scott Koenig},
  journal={Vaccine},
  year={2006},
  volume={24 Suppl 3},
  pages={
          S3/99-105
        }
}
We are now in the fortunate position of having two highly promising human papillomavirus (HPV) vaccines in the pipeline. Amidst the excitement of anticipating what these vaccines may be able to offer, it is worth pausing to look back at how the vaccine development story unfolded from an industrial perspective, since without the massive commitment shown by manufacturers over the last decade, without any guarantee of success, there would be no such prospect. This chapter focuses on the two HPV… CONTINUE READING
Highly Cited
This paper has 52 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

[Human papillomavirus vaccine. Efficacy and safety].

Enfermedades infecciosas y microbiologia clinica • 2015
View 4 Excerpts
Highly Influenced

Recurrent Respiratory Papillomatosis

Springer International Publishing • 2018

53 Citations

05'08'11'14'17
Citations per Year
Semantic Scholar estimates that this publication has 53 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Systemic immunization with papillomavirus L1 protein e 24S3

JA Suzich, SJ Ghim, +3 authors JA Bell
Proc Natl Acad Sci U S A • 1995
View 5 Excerpts
Highly Influenced

Immune responses to human papillomavirus

M. Stanley
Vaccine 2006;24(Suppl. 1):S16–22 • 2006
View 1 Excerpt

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology • 2005
View 1 Excerpt